The Group's principal activities are developing and commercializing specialty pharmaceutical products for the ophthalmic, neurological, dermatological and other specialty markets. It also performs pharmaceutical research, targeting products and technologies related to specific diseases such as glaucoma, retinal disease, dry eye, psoriasis, acne and movement disorders. The Group also develops and markets aesthetic-related pharmaceuticals and over-the-counter products. The Group operates mainly in the United States, Europe, Latin America and Asia Pacific.
Alacra Alerts:
Receive alerts on the latest reports on Allergan, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
